Market Place
Sourcing Support
Precision BioSciences to Report Q3 Results on Nov 4, 2024
29 Oct 2024 //
BUSINESSWIRE
Precision BioSciences Hosts Investor Event on PBGENE-HBV Data
28 Oct 2024 //
BUSINESSWIRE
Precision BioSciences Gets 1st Approval For Choronic Hepatitis B
24 Oct 2024 //
BUSINESSWIRE
Precision BioSciences Highlights ARCUS Data At ESGCT Congress
24 Oct 2024 //
BUSINESSWIRE
Precision Bio Joins Longwood Boston & Guggenheim Conferences
21 Oct 2024 //
BUSINESSWIRE
Precision BioSciences To Present At ESGCT 31st Annual Congress
16 Oct 2024 //
BUSINESSWIRE
Precision Bio To Present At H.C. Wainwright Hepatitis Conference
03 Oct 2024 //
BUSINESSWIRE
Precision BioSciences Submits Applications For PBGENE-HBV Trial
30 Sep 2024 //
BUSINESSWIRE
Precision BioSciences Grants Inducement Awards Under Nasdaq
21 Sep 2024 //
BUSINESSWIRE
Precision BioSciences Strengthens Leadership For PBGENE-HBV Trial
12 Sep 2024 //
BUSINESSWIRE
Precision BioSciences to Join H.C. Wainwright 26th Annual Healthcare Conference
04 Sep 2024 //
BUSINESSWIRE
Precision BioSciences Receives $13M from Imugene Convertible Note Maturity
03 Sep 2024 //
BUSINESSWIRE
TG Therapeutics Gets IND Clearance For Azer-Cel In Multiple Sclerosis
09 Aug 2024 //
BUSINESSWIRE
Precision BioSciences to Participate in Upcoming August Investor Conferences
31 Jul 2024 //
BUSINESSWIRE
Precision BioSciences to Report Second Quarter Results on August 1, 2024
29 Jul 2024 //
BUSINESSWIRE
Precision BioSciences To Present At JonesTrading Healthcare Seaside Summit
08 Jul 2024 //
BUSINESSWIRE
Precision BioSciences Announces its Addition to the Russell Microcap® Index
01 Jul 2024 //
BUSINESSWIRE
Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024
27 Jun 2024 //
BUSINESSWIRE
Precision BioSciences Adds Top Experts To Hepatitis Advisory Board
20 Jun 2024 //
BUSINESSWIRE
Precision Bio: PBGENE-HBV Preclinical Safety Data At EASL
05 Jun 2024 //
BUSINESSWIRE
Precision BioSciences to Participate in Upcoming June Investor Conferences
30 May 2024 //
BUSINESSWIRE
Precision Bio Reports Q1 2024 Results, Business Update
13 May 2024 //
BUSINESSWIRE
Precision BioSciences: Management Stock Purchase
08 May 2024 //
BUSINESSWIRE
Precision BioSciences to Report First Quarter Results on May 13, 2024
07 May 2024 //
BUSINESSWIRE
Precision Bio: EASL 2024 Late-Breaker On Gene Editing
01 May 2024 //
BUSINESSWIRE
Precision Bio Regains Programs, Ends Prevail Collaboration
16 Apr 2024 //
BUSINESSWIRE
Precision Reports Fourth Quarter and Fiscal Year 2023 Financial Results
27 Mar 2024 //
BUSINESSWIRE
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results
20 Mar 2024 //
BUSINESSWIRE
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM
19 Mar 2024 //
BUSINESSWIRE
Precision BioSciences Announces MHRA Approval for Partner iECURE
06 Mar 2024 //
BUSINESSWIRE
Precision Bio Announces $40.0 Million Offering of Common Stock and Warrants
01 Mar 2024 //
BUSINESSWIRE
Precision Bio Announces Proposed Public Offering of Common Stock and Warrants
29 Feb 2024 //
BUSINESSWIRE
Precision BioSciences Announces Proposed Public Offering of Common Stock
29 Feb 2024 //
PRESS RELEASE
Precision Announces Non-Exclusive Patent License Agreement with Caribou
20 Feb 2024 //
BUSINESSWIRE
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV
14 Feb 2024 //
BUSINESSWIRE
Precision Bio Promotes Naresh Tanna to Vice President of Investor Relations
13 Feb 2024 //
BUSINESSWIRE
Precision Bio Receives Initial $7.5 Million Cash Payment from TG Therapeutics
12 Feb 2024 //
BUSINESSWIRE
Precision BioSciences to Effect a Reverse Stock Split
09 Feb 2024 //
PRESS RELEASE
TG Therapeutics Announces Global License Agreement with Precision BioSciences
09 Jan 2024 //
GLOBENEWSWIRE
Precision deals out CAR-T autoimmune rights to TG for $10M
09 Jan 2024 //
FIERCE BIOTECH
Precision Announces Approval of First Trial Application of Gene Insertion Program
13 Dec 2023 //
BUSINESSWIRE
Precision BioSciences to Present at Hep-DART 2023
30 Nov 2023 //
BUSINESSWIRE
Precision Announces Grant of Inducement Award Under Nasdaq Listing 5635(c)(4)
28 Nov 2023 //
BUSINESSWIRE
Precision Bio Presents Late-Breaking Data Highlighting Safety of PBGENE-HBV
13 Nov 2023 //
BUSINESSWIRE
Precision BioSciences to Present at Upcoming Sidoti Conference
10 Nov 2023 //
BUSINESSWIRE
Precision BioSciences Announces Late-Breaking Poster Presentation
09 Nov 2023 //
BUSINESSWIRE
Precision BioSciences Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
BUSINESSWIRE
Precision Bio Presents Preclinical Data Highlighting Capabilities of ARCUS
26 Oct 2023 //
BUSINESSWIRE
Precision to Present at H.C. Wainwright 4th Annual Hepatitis B Virus Conference
23 Oct 2023 //
BUSINESSWIRE
Precision BioSciences to Present at the ESGCT 30th Annual Congress
12 Oct 2023 //
BUSINESSWIRE
Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM
27 Sep 2023 //
BUSINESSWIRE
Precision Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology
12 Sep 2023 //
BUSINESSWIRE
Precision Bio to Attend and Present at Upcoming September Investor Conferences
06 Sep 2023 //
BUSINESSWIRE
Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023
31 Aug 2023 //
BUSINESSWIRE
Precision Bio Completes Transaction with Imugene for Azer-Cel in Cancer
15 Aug 2023 //
BUSINESSWIRE
Precision BioSciences Reports Second Quarter 2023 Financial Results
04 Aug 2023 //
BUSINESSWIRE
Precision BioSciences to Report Second Quarter Results on August 4, 2023
01 Aug 2023 //
BUSINESSWIRE
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting
27 Jul 2023 //
BUSINESSWIRE
Precision BioSciences Announces Oral Presentation of +ve ARCUS® Gene Editing
22 Jun 2023 //
BUSINESSWIRE
